What's new

Human medicines European public assessment report (EPAR): Jardiance, empagliflozin, Date of authorisation: 22/05/2014, Revision: 31, Status: Authorised

Human medicines European public assessment report (EPAR): Jardiance, empagliflozin, Date of authorisation: 22/05/2014, Revision: 31, Status: Authorised

Apr 2, 2025 - 15:45
 0
Human medicines European public assessment report (EPAR): Jardiance, empagliflozin, Date of authorisation: 22/05/2014, Revision: 31, Status: Authorised
Human medicines European public assessment report (EPAR): Jardiance, empagliflozin, Date of authorisation: 22/05/2014, Revision: 31, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Extavia, interferon be...

Next Article

Lebanon and Syria’s plan to formalize borders a ‘postive’ step, needs follow-thr...

Related Posts

EMEA-003520-PIP01-23

EMEA-003520-PIP01-23

Mar 21, 2025  0

Human medicines European public assessment report (EPAR): Evusheld, tixagevimab,cilgavimab, Date of authorisation: 25/03/2022, Revision: 9, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 12, 2025  0

Opinion/decision on a Paediatric investigation plan (PIP): Enerzair Breezhaler, Indacaterol (acetate),Mometasone (furoate),Glycopyrronium bromide, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Pneumology-allergology, PIP number: P/0493/2023

Opinion/decision on a Paediatric investigation plan (PI...

Feb 15, 2025  0